Literature DB >> 3341282

Evaluation of a latex agglutination test for diagnosis of Clostridium difficile-associated colitis.

M E Sherman1, P C DeGirolami, G M Thorne, J Kimber, K Eichelberger.   

Abstract

Current methods for diagnosis of Clostridium difficile-associated colitis (CAC) based on detection of cytotoxin B by a tissue culture assay (TCA) require technical expertise and up to 48 hours incubation. Recently, a latex agglutination (LA) test (Marion Laboratories) for rapid diagnosis of CAC has become available. Although early evaluations have been favorable, new evidence suggests that the LA reagent binds a soluble bacterial antigen that is not unique to toxigenic strains of C. difficile. The authors examined 201 stools received for CAC testing by LA and a reference TCA and investigated discrepant results. They obtained 29 LA(+)/TCA(+) and 155 LA(-)/TCA(-) results. Eleven patients had LA(+)/TCA(+) and 155 LA(-)/TCA(-) results. Eleven patients had LA(+)/TCA(-) results and 6 had LA(-)/TCA(+) results. The sensitivity and specificity of the LA were 83% and 93%, respectively, compared with TCA. The predictive values of positive and negative results obtained with the LA were 72% and 96%, respectively. Concentrated broth supernatants and live suspensions of three C. difficile isolates with LA(+)/TCA(-) results were tested in a rabbit ileal loop assay. All failed to demonstrate ability to produce an enterotoxin. The authors conclude that the LA method is suitable for rapid screening, but LA(+) results require confirmation by testing with other methods.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341282     DOI: 10.1093/ajcp/89.2.228

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A.

Authors:  P C De Girolami; P A Hanff; K Eichelberger; L Longhi; H Teresa; J Pratt; A Cheng; J M Letourneau; G M Thorne
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  Treatment of acute uncomplicated urinary tract infection with ceftibuten.

Authors:  G E Stein; S Christensen; N Mummaw
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

3.  Comparison of culture, cytotoxin assay and two EIA tests with clinical diagnosis of Clostridium difficile-associated diarrhea.

Authors:  M Binning; M A John; B C Schieven; T W Austin; R Lannigan; Z Hussain
Journal:  Can J Infect Dis       Date:  1994-07

Review 4.  Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy.

Authors:  Munshi Moyenuddin; John C Williamson; Christopher A Ohl
Journal:  Curr Gastroenterol Rep       Date:  2002-08

Review 5.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases.

Authors:  S Whittier; D S Shapiro; W F Kelly; T P Walden; K J Wait; L T McMillon; P H Gilligan
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

7.  Evaluation of a commercial latex test for Clostridium difficile for reactivity with C. difficile and cross-reactions with other bacteria.

Authors:  B L Miles; J A Siders; S D Allen
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

8.  Evaluation of a latex agglutination test for Clostridium difficile in two nursing home outbreaks.

Authors:  R G Bennett; B E Laughon; L M Mundy; L D Bobo; C A Gaydos; W B Greenough; J G Bartlett
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

9.  Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays.

Authors:  G V Doern; R T Coughlin; L Wu
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.